# RNXT (Renovorx, Inc.) - SEC EDGAR Financial Statements

> Renovorx, Inc. reported $2.78M in revenue and a net loss of $13.02M for the trailing twelve months ended September 30, 2026 (up 300.8% year over year), with a 84.0% gross margin and a -489.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/RNXT
- Markdown: https://convexityos.com/fundamentals/RNXT.md
- SEC CIK: 0001574094
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001574094&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.78M | +300.8% YoY |
| Operating Income | TTM | -$13.58M | -489.0% margin |
| Net Income | TTM | -$13.02M | -469.0% net margin |
| Diluted EPS | TTM | -$0.27 | Split-adjusted |
| Free Cash Flow | TTM | -$12.22M | -440.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $10.40M | Total debt: $358K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.12M | $43K | -- | -- | -- | -- |
| Cost of Revenue | $327K | $0 | -- | -- | -- | -- |
| **Gross Profit** | $796K | $43K | -- | -- | -- | -- |
| Research & Development | $6.27M | $6.03M | $5.67M | $4.30M | $3.04M | $2.39M |
| Selling, General & Admin | $7.04M | $4.99M | $5.73M | -- | -- | -- |
| Total Operating Expenses | $13.31M | $11.01M | $11.40M | $9.95M | $5.67M | $3.20M |
| **Operating Income** | -$12.51M | -$10.97M | -$11.40M | -$9.95M | -$5.67M | -$3.20M |
| **EBITDA** | -$10.51M | -$10.97M | -- | -- | -- | -- |
| Income Before Tax | -$11.17M | -$8.75M | -- | -- | -- | -- |
| Income Tax Expense | $2.0K | -- | -- | -- | -- | -- |
| **Net Income** | -$11.17M | -$8.81M | -$10.23M | -$9.89M | -$6.32M | -$3.80M |
| Basic EPS | -$0.32 | -$0.40 | -$0.99 | -$1.09 | -$1.21 | -$1.72 |
| **Diluted EPS** | -$0.32 | -$0.40 | -$0.99 | -$1.09 | -$1.21 | -$1.72 |
| Basic Shares Outstanding | 35.3M | 22.3M | 10.3M | 9.1M | 5.2M | 2.2M |
| Diluted Shares Outstanding | 35.3M | 22.3M | 10.3M | 9.1M | 5.2M | 2.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.07M | $909K | $563K | $238K | $266K | $422K | $197K | -- |
| Cost of Revenue | $188K | $143K | $84K | $28K | $53K | $152K | $94K | -- |
| **Gross Profit** | $878K | $766K | $479K | $210K | $213K | $270K | $103K | -- |
| Research & Development | $1.24M | $1.20M | $1.23M | $1.50M | $1.69M | $1.43M | $1.64M | $1.58M |
| Selling, General & Admin | $2.87M | $2.92M | $2.72M | $2.23M | $1.73M | $1.52M | $1.57M | $1.10M |
| Total Operating Expenses | $4.11M | $4.12M | $3.95M | $3.73M | $3.41M | $2.95M | $3.21M | $2.67M |
| **Operating Income** | -$3.24M | -$3.35M | -$3.47M | -$3.52M | -$3.20M | -$2.68M | -$3.11M | -$2.63M |
| **EBITDA** | -$3.23M | -$3.34M | -$3.47M | -$3.52M | -$2.20M | -$1.68M | -$3.11M | -- |
| Income Tax Expense | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | -- |
| **Net Income** | -$3.65M | -$2.91M | -$3.52M | -$2.94M | -$2.91M | -$2.90M | -$2.42M | -$2.88M |
| Basic EPS | -$0.08 | -$0.06 | -$0.09 | -- | -$0.08 | -$0.08 | -$0.08 | -- |
| **Diluted EPS** | -$0.08 | -$0.06 | -$0.09 | -- | -$0.08 | -$0.08 | -$0.08 | -- |
| Basic Shares Outstanding | 48.2M | 47.3M | 38.0M | -- | 36.6M | 36.6M | 31.4M | -- |
| Diluted Shares Outstanding | 48.2M | 47.3M | 38.0M | -- | 36.6M | 36.6M | 31.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.02M | $7.15M | $1.17M | $4.39M | $15.19M | $1.79M |
| Short-Term Investments | -- | -- | -- | $2.05M | -- | -- |
| **Cash & Short-Term Investments** | $7.02M | $7.15M | $1.17M | $6.40M | $15.19M | $1.79M |
| Accounts Receivable, Net | $139K | $43K | -- | -- | -- | -- |
| Inventory | $189K | $0 | -- | -- | -- | -- |
| Other Current Assets | $217K | $303K | $24K | -- | -- | -- |
| **Total Current Assets** | $7.89M | $7.83M | $1.47M | $7.26M | $16.28M | $1.91M |
| Property, Plant & Equipment, Net | $12K | $12K | -- | -- | -- | -- |
| Other Non-Current Assets | $0 | -- | -- | -- | -- | $4.0K |
| **Total Non-Current Assets** | $202K | $290K | $0 | $0 | $6.0K | $4.0K |
| **Total Assets** | $8.10M | $8.12M | $1.47M | $7.26M | $16.29M | $1.91M |
| Accounts Payable | $799K | $586K | $561K | $534K | $525K | $162K |
| **Total Current Liabilities** | $1.96M | $1.91M | $1.18M | $1.10M | $938K | $4.10M |
| **Total Non-Current Liabilities** | $711K | $1.73M | $3.29M | $0 | $0 | $23K |
| **Total Liabilities** | $2.67M | $3.64M | $4.47M | $1.10M | $938K | $4.12M |
| **Total Debt (incl. Leases)** | $212K | $278K | -- | -- | $30K | -- |
| Common Stock | $4.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$61.39M | -$50.22M | -$41.41M | -$31.17M | -$21.28M | -$14.96M |
| Accumulated Other Comp. Income | -- | -- | -- | $17K | -- | -- |
| **Total Stockholders' Equity** | $5.42M | $4.48M | $3.00M | $6.16M | $15.35M | -$14.66M |
| Total Equity | $5.42M | $4.48M | $3.00M | $6.16M | $15.35M | -$14.66M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.40M | $9.48M | $12.36M | $7.02M | $10.04M | $12.31M | $14.58M | $7.15M |
| **Cash & Short-Term Investments** | $10.40M | $9.48M | $12.36M | $7.02M | $10.04M | $12.31M | $14.58M | $7.15M |
| Accounts Receivable, Net | $609K | $480K | $280K | $139K | $169K | $363K | $242K | $43K |
| Inventory | $341K | $383K | $379K | $189K | $272K | -- | -- | $0 |
| Other Current Assets | $195K | $153K | $198K | $217K | $145K | $288K | $444K | $303K |
| **Total Current Assets** | $11.81M | $10.81M | $13.72M | $7.89M | $10.98M | $13.39M | $15.74M | $7.83M |
| Property, Plant & Equipment, Net | $89K | $94K | $77K | $12K | $13K | $13K | $13K | $12K |
| Other Non-Current Assets | $200K | $200K | -- | $0 | -- | -- | -- | -- |
| **Total Non-Current Assets** | $623K | $662K | $244K | $202K | $226K | $248K | $269K | $290K |
| **Total Assets** | $12.44M | $11.47M | $13.96M | $8.10M | $11.21M | $13.64M | $16.01M | $8.12M |
| Accounts Payable | $938K | $866K | $1.12M | $799K | $869K | $671K | $967K | $586K |
| **Total Current Liabilities** | $2.09M | $1.88M | $1.92M | $1.96M | $1.88M | $1.56M | $1.74M | $1.91M |
| **Total Non-Current Liabilities** | $1.06M | $609K | $779K | $711K | $1.24M | $1.45M | $1.12M | $1.73M |
| **Total Liabilities** | $3.15M | $2.49M | $2.70M | $2.67M | $3.13M | $3.00M | $2.86M | $3.64M |
| **Total Debt (incl. Leases)** | $358K | $390K | $186K | $212K | $236K | $260K | $283K | $278K |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K |
| Retained Earnings | -$71.47M | -$67.82M | -$64.91M | -$61.39M | -$58.45M | -$55.53M | -$52.64M | -$50.22M |
| **Total Stockholders' Equity** | $9.28M | $8.98M | $11.27M | $5.42M | $8.08M | $10.64M | $13.16M | $4.48M |
| Total Equity | $9.28M | $8.98M | $11.27M | $5.42M | $8.08M | $10.64M | $13.16M | $4.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.17M | -$8.81M | -$10.23M | -$9.89M | -$6.32M | -$3.80M |
| Depreciation & Amortization | $2.00M | $0 | -- | -- | -- | -- |
| Stock-Based Compensation | $1.27M | $1.17M | $1.08M | $644K | $147K | $33K |
| Change in Inventory | -$189K | $0 | -- | -- | -- | -- |
| Change in Payables | $213K | $25K | $27K | $9.0K | $363K | -$376K |
| **Operating Cash Flow** | -$10.97M | -$9.12M | -$10.26M | -$8.81M | -$5.92M | -$3.53M |
| Capital Expenditure | -$2.0K | -$12K | -- | -- | -- | -- |
| **Free Cash Flow** | -$10.97M | -$9.14M | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -$8.00M | -- | -- |
| **Investing Cash Flow** | -$2.0K | -$12K | $2.03M | -$2.03M | -$15K | -- |
| Common Stock Issued | $12.10M | $17.25M | $5.00M | -- | $14.56M | -- |
| **Financing Cash Flow** | $10.85M | $15.12M | $5.01M | $42K | $19.33M | $3.20M |
| **Net Change in Cash** | -$130K | $5.98M | -$3.22M | -$10.80M | $13.40M | -$329K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.65M | -$2.91M | -$3.52M | -$2.94M | -$2.91M | -$2.90M | -$2.42M | -$2.88M |
| Depreciation & Amortization | $5.0K | $5.0K | $1.0K | $1.0K | $1.00M | $1.00M | $1.0K | -- |
| Stock-Based Compensation | $469K | $570K | $317K | $285K | $349K | $345K | $288K | $252K |
| Change in Receivables | -- | -- | -- | -- | $194K | -$121K | -$199K | -- |
| Change in Inventory | $42K | -$4.0K | -$190K | $83K | -$272K | $0 | $0 | -- |
| Change in Payables | $91K | -$206K | $254K | -$70K | $198K | -$296K | $381K | -$100K |
| **Operating Cash Flow** | -$2.54M | -$2.87M | -$3.71M | -$3.02M | -$2.27M | -$2.30M | -$3.38M | -$2.43M |
| Capital Expenditure | -$19K | -$71K | $0 | $0 | $0 | $0 | -$2.0K | -- |
| **Free Cash Flow** | -$2.56M | -$2.94M | -$3.71M | -$3.02M | -$2.27M | -$2.30M | -$3.38M | -- |
| **Investing Cash Flow** | -$19K | -$71K | $0 | $0 | $0 | $0 | -$2.0K | -- |
| Common Stock Issued | $0 | $0 | $10.00M | $0 | $0 | $0 | $12.10M | $0 |
| **Financing Cash Flow** | $3.48M | $55K | $9.05M | $0 | $0 | $34K | $10.81M | $33K |
| **Net Change in Cash** | $925K | -$2.88M | $5.34M | -$3.02M | -$2.27M | -$2.27M | $7.43M | -$2.41M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 70.9% | 100.0% | -- | -- | -- | -- |
| **Operating Margin** | -1114.0% | -25511.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -994.5% | -20497.7% | -- | -- | -- | -- |
| Return on Equity (ROE) | -206.0% | -196.8% | -341.1% | -160.5% | -41.2% | -- |
| Return on Assets (ROA) | -138.0% | -108.6% | -698.0% | -136.1% | -38.8% | -198.4% |
| Current Ratio | 4.02x | 4.10x | 1.25x | 6.59x | 17.36x | 0.47x |
| Quick Ratio | 3.93x | 4.10x | 1.00x | 5.81x | 16.20x | 0.44x |
| Debt to Equity | 0.04x | 0.06x | -- | -- | 0.00x | -- |
| **Revenue Growth (YoY)** | +2511.6% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +1751.2% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 84.0% | 84.4% | 78.7% | 70.9% | -- | -- | -- | -- |
| **Operating Margin** | -489.0% | -685.2% | -864.3% | -1114.0% | -- | -- | -- | -- |
| **Net Profit Margin** | -469.0% | -621.7% | -824.0% | -994.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -140.2% | -136.8% | -108.9% | -206.0% | -137.5% | -100.2% | -77.2% | -196.8% |
| Return on Assets (ROA) | -104.7% | -107.1% | -87.9% | -138.0% | -99.1% | -78.2% | -63.4% | -108.6% |
| Current Ratio | 5.65x | 5.74x | 7.15x | 4.02x | 5.83x | 8.61x | 9.07x | 4.10x |
| Quick Ratio | 5.49x | 5.53x | 6.95x | 3.93x | 5.68x | 8.15x | 8.54x | 4.10x |
| Debt to Equity | 0.04x | 0.04x | 0.02x | 0.04x | 0.03x | 0.02x | 0.02x | 0.06x |
| **Revenue Growth (YoY)** | +300.8% | +115.4% | +185.8% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +312.2% | +183.7% | +365.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
